Watts T H, Brian A A, Kappler J W, Marrack P, McConnell H M
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7564-8. doi: 10.1073/pnas.81.23.7564.
I-Ad, purified from A20-1.11 cells by affinity chromatography, was incorporated into supported planar membranes by incubation of I-Ad-containing phospholipid vesicles with clean glass coverslips. Such planar membranes present a peptide digest of ovalbumin to the ovalbumin-specific, I-Ad-restricted T-cell hybridoma 3DO-54.8, resulting in the antigen-specific release of interleukin 2. However, when the same material was provided in the form of small unilamellar vesicles, no response was obtained. Antigen presentation by the I-Ad-containing planar membranes was inhibited by the monoclonal antibody MKD6 (anti-I-Ad) but not by the antibody 10-2.16 (anti-I-Ak). The antibody GK1.5, which recognizes the T-cell surface antigen L3T4, was also inhibitory. In contrast to the results with purified I-Ad, crude membrane preparations from A20-1.11 cells were effective in antigen presentation in both planar and vesicular forms.
通过亲和层析从A20 - 1.11细胞中纯化得到的I - Ad,通过将含I - Ad的磷脂囊泡与干净的玻璃盖玻片孵育,被整合到支持的平面膜中。这种平面膜将卵清蛋白的肽消化产物呈递给卵清蛋白特异性的、受I - Ad限制的T细胞杂交瘤3DO - 54.8,导致白细胞介素2的抗原特异性释放。然而,当以小单层囊泡的形式提供相同物质时,未获得反应。含I - Ad的平面膜的抗原呈递被单克隆抗体MKD6(抗I - Ad)抑制,但不被抗体10 - 2.16(抗I - Ak)抑制。识别T细胞表面抗原L3T4的抗体GK1.5也具有抑制作用。与纯化的I - Ad的结果相反,来自A20 - 1.11细胞的粗膜制剂在平面和囊泡形式的抗原呈递中均有效。